Owner only: item control page
CAR-T-Zellen als Arzneimittel für neuartige Therapien (Advanced Therapy Medicinal Products)
Köhl, Ulrike and Abken, Hinrich (2021) CAR-T-Zellen als Arzneimittel für neuartige Therapien (Advanced Therapy Medicinal Products). Der Internist 62 (4), pp. 449-457.Date of publication of this fulltext: 29 Feb 2024 12:25
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Der Internist | ||||
| Publisher: | SPRINGER HEIDELBERG | ||||
|---|---|---|---|---|---|
| Place of Publication: | HEIDELBERG | ||||
| Volume: | 62 | ||||
| Number of Issue or Book Chapter: | 4 | ||||
| Page Range: | pp. 449-457 | ||||
| Date | 2021 | ||||
| Institutions | Leibniz Institute for Immunotherapy (LIT) | ||||
| Identification Number |
| ||||
| Keywords | ; Receptors; chimeric antigen; Immunotherapy; adoptive; Axicabtagene ciloleucel; Tisagenlecleucel; Good manufacturing practice | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 55993 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric